India to resume regular international flight operations from March 27

Earlier on February 28, the DGCA extended the ban on regular international flights, until further orders.

Moneycontrol News

March 08, 2022 / 17:57 IST

Mumbai International Airport (Representative Image)

The Civil Aviation Ministry on March 8 announced that it will resume regular international flight operations from March 27.

"After having recognized the increased vaccination coverage across the globe and in consultation with the stakeholders, the Government of India has decided to resume scheduled commercial international passenger services to/from India from 27.03.2022, i.e. start of Summer Schedule 2022. The suspension of scheduled commercial international passenger services to/from India, thus, stands extended only upto 2359 hrs IST on 26.03.2022 and air bubble arrangements shall accordingly be extended to this extent only," the ministry said in a statement.

The ministry further added that international operations shall be subject to strict adherence to Ministry of Health guidelines for international travel.

Earlier on February 28, the Directorate General of Civil Aviation (DGCA) extended the ban on regular international flights, until further orders. However, the DGCA said that the flights that are operational under air bubble arrangements as well as international cargo flights will continue to operate as scheduled.

The Scheduled international flight services have remained suspended in India since March 23, 2020. However, special international flights have been operating between India and about 35 other countries since July 2020 under air bubble arrangements. India currently has air transport bubbles with 40 countries, including Canada, France, Germany, United Arab Emirates, the United Kingdom, and the US.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show